Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 95

1.

Ultrafiltration Rate Thresholds in Maintenance Hemodialysis: An NKF-KDOQI Controversies Report.

Kramer H, Yee J, Weiner DE, Bansal V, Choi MJ, Brereton L, Berns JS, Samaniego-Picota M, Scheel P Jr, Rocco M.

Am J Kidney Dis. 2016 Oct;68(4):522-532. doi: 10.1053/j.ajkd.2016.06.010. Epub 2016 Jul 19.

PMID:
27449697
2.

CLINICAL PROBLEM-SOLVING. From Dancing to Debilitated.

Houston BA, Miller PE, Rooper LM, Scheel PJ Jr, Gelber AC.

N Engl J Med. 2016 Feb 4;374(5):470-7. doi: 10.1056/NEJMcps1311794. No abstract available.

PMID:
26840137
3.

KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update.

National Kidney Foundation.

Am J Kidney Dis. 2015 Nov;66(5):884-930. doi: 10.1053/j.ajkd.2015.07.015. Review. Erratum in: Am J Kidney Dis. 2016 Mar;67(3):534.

PMID:
26498416
4.

Rituximab for the Treatment of IgG4-Related Tubulointerstitial Nephritis: Case Report and Review of the Literature.

McMahon BA, Novick T, Scheel PJ, Bagnasco S, Atta MG.

Medicine (Baltimore). 2015 Aug;94(32):e1366. doi: 10.1097/MD.0000000000001366. Review.

5.

Does surgeon experience affect outcomes in pathologic stage I lung cancer?

Scheel PJ 3rd, Crabtree TD, Bell JM, Frederiksen C, Broderick SR, Krupnick AS, Kreisel D, Patterson GA, Meyers BF, Puri V.

J Thorac Cardiovasc Surg. 2015 Apr;149(4):998-1004.e1. doi: 10.1016/j.jtcvs.2014.12.032. Epub 2014 Dec 20.

6.

Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study.

Tangri N, Miskulin DC, Zhou J, Bandeen-Roche K, Michels WM, Ephraim PL, McDermott A, Crews DC, Scialla JJ, Sozio SM, Shafi T, Jaar BG, Meyer K, Boulware LE; DEcIDE Network Patient Outcomes in End-Stage Renal Disease Study Investigators.

Nephrol Dial Transplant. 2015 Apr;30(4):667-75. doi: 10.1093/ndt/gfu349. Epub 2014 Nov 2.

7.

Intravenous iron exposure and mortality in patients on hemodialysis.

Miskulin DC, Tangri N, Bandeen-Roche K, Zhou J, McDermott A, Meyer KB, Ephraim PL, Michels WM, Jaar BG, Crews DC, Scialla JJ, Sozio SM, Shafi T, Wu AW, Cook C, Boulware LE; Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) Network Patient Outcomes in End Stage Renal Disease Study Investigators.

Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1930-9. doi: 10.2215/CJN.03370414. Epub 2014 Oct 15.

8.

Generation and detection of gigahertz acoustic oscillations in thin membranes.

Schubert M, Grossmann M, He C, Brick D, Scheel P, Ristow O, Gusev V, Dekorsy T.

Ultrasonics. 2015 Feb;56:109-15. doi: 10.1016/j.ultras.2014.06.018. Epub 2014 Jul 24.

PMID:
25149196
9.

Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease.

Diamond EL, Dagna L, Hyman DM, Cavalli G, Janku F, Estrada-Veras J, Ferrarini M, Abdel-Wahab O, Heaney ML, Scheel PJ, Feeley NK, Ferrero E, McClain KL, Vaglio A, Colby T, Arnaud L, Haroche J.

Blood. 2014 Jul 24;124(4):483-92. doi: 10.1182/blood-2014-03-561381. Epub 2014 May 21.

10.

An instrumental variable approach finds no associated harm or benefit with early dialysis initiation in the United States.

Scialla JJ, Liu J, Crews DC, Guo H, Bandeen-Roche K, Ephraim PL, Tangri N, Sozio SM, Shafi T, Miskulin DC, Michels WM, Jaar BG, Wu AW, Powe NR, Boulware LE; DEcIDE Network Patient Outcomes in End Stage Renal Disease Study Investigators.

Kidney Int. 2014 Oct;86(4):798-809. doi: 10.1038/ki.2014.110. Epub 2014 Apr 30. Erratum in: Kidney Int. 2016 Apr;89(4):957. Kim, Jeonyong [corrected to Kim, Jeongyong].

11.

Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD.

Crews DC, Scialla JJ, Boulware LE, Navaneethan SD, Nally JV Jr, Liu X, Arrigain S, Schold JD, Ephraim PL, Jolly SE, Sozio SM, Michels WM, Miskulin DC, Tangri N, Shafi T, Wu AW, Bandeen-Roche K; DEcIDE Network Patient Outcomes in End Stage Renal Disease Study Investigators.

Am J Kidney Dis. 2014 May;63(5):806-15. doi: 10.1053/j.ajkd.2013.12.010. Epub 2014 Feb 6.

12.

Predialysis systolic BP variability and outcomes in hemodialysis patients.

Shafi T, Sozio SM, Bandeen-Roche KJ, Ephraim PL, Luly JR, St Peter WL, McDermott A, Scialla JJ, Crews DC, Tangri N, Miskulin DC, Michels WM, Jaar BG, Herzog CA, Zager PG, Meyer KB, Wu AW, Boulware LE; DEcIDE Network Patient Outcomes in End Stage Renal Disease Study Investigators.

J Am Soc Nephrol. 2014 Apr;25(4):799-809. doi: 10.1681/ASN.2013060667. Epub 2014 Jan 2.

13.

Trends in anemia management in US hemodialysis patients 2004-2010.

Miskulin DC, Zhou J, Tangri N, Bandeen-Roche K, Cook C, Ephraim PL, Crews DC, Scialla JJ, Sozio SM, Shafi T, Jaar BG, Boulware LE; DEcIDE Network Patient Outcomes in End Stage Renal Disease Study Investigators.

BMC Nephrol. 2013 Dec 1;14:264. doi: 10.1186/1471-2369-14-264.

14.

Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months.

St Peter WL, Sozio SM, Shafi T, Ephraim PL, Luly J, McDermott A, Bandeen-Roche K, Meyer KB, Crews DC, Scialla JJ, Miskulin DC, Tangri N, Jaar BG, Michels WM, Wu AW, Boulware LE; DEcIDE Network Patient Outcomes in End-Stage Renal Disease Study Investigators.

BMC Nephrol. 2013 Nov 12;14:249. doi: 10.1186/1471-2369-14-249.

15.

Predialysis health, dialysis timing, and outcomes among older United States adults.

Crews DC, Scialla JJ, Liu J, Guo H, Bandeen-Roche K, Ephraim PL, Jaar BG, Sozio SM, Miskulin DC, Tangri N, Shafi T, Meyer KB, Wu AW, Powe NR, Boulware LE; Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) Patient Outcomes in End Stage Renal Disease Study Investigators.

J Am Soc Nephrol. 2014 Feb;25(2):370-9. doi: 10.1681/ASN.2013050567. Epub 2013 Oct 24.

16.

Retroperitoneal fibrosis.

Scheel PJ Jr, Feeley N.

Rheum Dis Clin North Am. 2013 May;39(2):365-81. doi: 10.1016/j.rdc.2013.02.004. Epub 2013 Mar 9. Review.

PMID:
23597969
17.

Medical management of retroperitoneal fibrosis.

Scheel PJ Jr, Sozio SM, Feeley N.

Trans Am Clin Climatol Assoc. 2012;123:283-90; discussion 290-1.

18.

Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study.

Boulware LE, Tangri N, Ephraim PL, Scialla JJ, Sozio SM, Crews DC, Shafi T, Miskulin DC, Liu J, St Peter W, Jaar BG, Wu AW, Powe NR, Navaneethan SD, Bandeen-Roche K; DEcIDE ESRD Patient Outcomes in Renal Disease Study Investigators.

BMC Nephrol. 2012 Dec 6;13:167. doi: 10.1186/1471-2369-13-167.

19.

The effect of vasospasm on cerebral perfusion: a colour duplex study of the extra- and intracranial cerebral arteries.

Schöning M, Scheel P, Wittibschläger J, Kehrer M, Will BE.

Ultrasound Med Biol. 2012 Mar;38(3):360-7. doi: 10.1016/j.ultrasmedbio.2011.12.013. Epub 2012 Jan 21.

PMID:
22266230
20.

Retroperitoneal fibrosis: gaining traction on an enigma.

Swartz R, Scheel P.

Lancet. 2011 Jul 23;378(9788):294-6. doi: 10.1016/S0140-6736(11)60880-5. Epub 2011 Jul 4. No abstract available.

PMID:
21733569

Supplemental Content

Loading ...
Support Center